The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRosslyn Data Regulatory News (RDT)

Share Price Information for Rosslyn Data (RDT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 9.75
Bid: 9.50
Ask: 10.00
Change: 0.00 (0.00%)
Spread: 0.50 (5.263%)
Open: 9.75
High: 9.75
Low: 9.75
Prev. Close: 9.75
RDT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Dealing and Issue of Equity

25 Jul 2018 11:14

RNS Number : 7355V
Rosslyn Data Technologies PLC
25 July 2018
 

25 July 2018

Rosslyn Data Technologies plc

(the "Company")

Director/PDMR Dealing and Issue of Equity

Further to the Company's announcement on 23 July 2018 regarding the appointment of James Appleby as a non-executive director, the Company is pleased to announce that on 23 July 2018 Mr Appleby subscribed for 4,545,454 new ordinary shares of 0.5 pence each in the capital of the Company ("Ordinary Shares") at a subscription price of 5.50 pence per Ordinary Share (the "Subscription"). Following the Subscription, Mr Appleby holds 4,545,454 Ordinary Shares representing approximately 2.3% per cent of the Company's issued share capital.

Accordingly, an application has been made for the admission to trading of 4,545,454 new Ordinary Shares to satisfy the subscription by Mr Appleby. It is expected that Admission of the new Ordinary Shares will occur at 8:00 a.m. on 31 July 2018. Following Admission, the Company will have 192,675,521 Ordinary Shares in issue. Therefore, the total number of Ordinary Shares with voting rights in the Company is 192,675,521. This figure, 192,675,521, may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change of their interest in, the Company under the FCA's Disclosure and Transparency Rules.

Commenting John O' Hara said; "This subscription is a strong endorsement from James in Rosslyn and its capabilities. The Subscription brings additional funds into the Company and whilst there is no need for additional operational cash at this time, the Board welcomes the cash injection as it provides us with the flexibility to repay the loan notes outstanding from the Integritie acquisition without straining the Company's existing cash resources."

The Company makes the following disclosures in accordance with article 19(3) of the Market Abuse Regulation: 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

James Appleby

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Non-Executive Director

b)

 

Initial notification /Amendment

 

 

Initial

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

ROSSLYN DATA TECHNOLOGIES PLC

b)

 

LEI

 

 

213800UJ7YTBGGXGJN09

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

Ordinary Shares of 0.5 pence each

 

 

ISIN: GB00BKX5CP01

 

b)

 

Nature of the transaction

 

 

Subscription for new Ordinary Shares

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

5.50p

4,545,454

 

 

d)

 

Aggregated information

- Aggregated volume

 

- Price

 

 

 

 

N/A - single transaction

 

 

 

e)

 

Date of the transaction

 

 

23 July 2018

f)

 

Place of the transaction

 

 

Outside of trading venue

 

 

Rosslyn Data Technologies plc

Roger Bullen,

Chief Executive Officer

 

+44(0)20 7138 3203

+44(0)77 7162 3345

 

Lance Mercereau

Chief Marketing Officer

 

 

+44(0)7788 183273

Cenkos Securities -

Nominated Adviser, Broker

Stephen Keys

 

+44(0)20 7397 8924

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHRAMMTMBMTBPP
Date   Source Headline
28th Mar 202412:56 pmRNSHolding(s) in Company
28th Mar 202412:55 pmRNSHolding(s) in Company
6th Mar 202411:49 amRNSHolding(s) in Company
4th Mar 202411:47 amRNSHolding(s) in Company
4th Mar 20247:00 amRNSTrading Update
25th Jan 20246:07 pmRNSReplacement- Interim Results
25th Jan 20247:00 amRNSInterim Results
12th Jan 20249:54 amRNSHolding(s) in Company
12th Jan 20249:52 amRNSHolding(s) in Company
4th Jan 20242:21 pmRNSChange of Registered Address
12th Dec 202311:24 amRNSChange of Nominated Adviser and Broker
8th Dec 20234:42 pmRNSHolding(s) in Company
24th Nov 202312:43 pmRNSHolding(s) in Company
23rd Nov 20231:31 pmRNSResult of AGM
31st Oct 20237:00 amRNSFinal Results, Annual Report and Notice of AGM
27th Oct 20234:15 pmRNSHolding(s) in Company
17th Oct 202312:46 pmRNSHolding(s) in Company
17th Oct 202310:10 amRNSHolding(s) in Company
5th Oct 202310:21 amRNSHolding(s) in Company
2nd Oct 20237:00 amRNSDirectorate Change
26th Sep 202311:08 amRNSHolding(s) in Company
25th Sep 20235:28 pmRNSTR1 - NOTIFICATION OF MAJOR HOLDINGS
25th Sep 20234:51 pmRNSHolding(s) in Company
25th Sep 20233:52 pmRNSHolding(s) in Company
22nd Sep 202311:52 amRNSHolding(s) in Company
21st Sep 202312:43 pmRNSHolding(s) in Company
21st Sep 202312:37 pmRNSHolding(s) in Company
20th Sep 20237:00 amRNSShare Consolidation and Total Voting Rights
19th Sep 20238:07 amRNSDirector Dealings
18th Sep 202312:09 pmRNSResult of General Meeting
5th Sep 20235:02 pmRNSResult of Retail Offer
31st Aug 20237:00 amRNSResult of Placing and Posting of Circular
30th Aug 20234:35 pmRNSRetail Offer
30th Aug 20234:30 pmRNSProposed Placing, Loan Note Issue & Notice of GM
30th May 20237:00 amRNSRosslyn wins two new contracts
11th Apr 20234:40 pmRNSHolding(s) in Company
6th Apr 20237:00 amRNSTrading Update
9th Mar 20239:48 amRNSHolding(s) in Company
31st Jan 202311:05 amRNSSecond Price Monitoring Extn
31st Jan 202311:00 amRNSPrice Monitoring Extension
31st Jan 20239:05 amRNSSecond Price Monitoring Extn
31st Jan 20239:00 amRNSPrice Monitoring Extension
30th Jan 20234:40 pmRNSSecond Price Monitoring Extn
30th Jan 20234:35 pmRNSPrice Monitoring Extension
30th Jan 20232:05 pmRNSSecond Price Monitoring Extn
30th Jan 20232:00 pmRNSPrice Monitoring Extension
30th Jan 202311:05 amRNSSecond Price Monitoring Extn
30th Jan 202311:00 amRNSPrice Monitoring Extension
30th Jan 20237:00 amRNSRosslyn wins new multi-year contract
30th Jan 20237:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.